Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$521M |
| 2 |
Nike
NKE
|
+$509M |
| 3 |
Micron Technology
MU
|
+$439M |
| 4 |
Super Micro Computer
SMCI
|
+$435M |
| 5 |
Broadcom
AVGO
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$5.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.89B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Microsoft
MSFT
|
+$1.07B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.38% |
| 2 | Consumer Discretionary | 1.03% |
| 3 | Financials | 0.75% |
| 4 | Healthcare | 0.67% |
| 5 | Communication Services | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11351
LanzaTech
LNZA
$80.9M
| $50.4K | ﹤0.01% |
272
-214
| -44% | -$54.5K |
|
11352
PUT
Taysha Gene Therapies
TSHA
$1.96B
| $50.2K | ﹤0.01% |
+22,400
| New | +$65.2K |
|
|
CANG
11353
Cango Inc
CANG
$97.6M
| $50.1K | ﹤0.01% |
3,002
-729
| -20% | -$11.2K |
|
|
PVL
11354
Permianville Royalty Trust
PVL
$59.6M
| $50.1K | ﹤0.01% |
48,244
-48,626
| -50% | -$66.7K |
|
11355
PUT
Capricor Therapeutics
CAPR
$544M
| $50.1K | ﹤0.01% |
10,500
-17,400
| -62% | -$97K |
|
11356
Rimini Street
RMNI
$481M
| $50.1K | ﹤0.01% |
16,312
+4,109
| +34% | +$11.3K |
|
11357
PUT
Hyliion Holdings
HYLN
$593M
| $50.1K | ﹤0.01% |
30,900
-55,200
| -64% | -$82K |
|
11358
PUT
Senseonics Holdings Inc
SENS
$494M
| $49.8K | ﹤0.01% |
6,220
-30
| -0.5% | -$267 |
|
11359
Dynagas LNG Partners
DLNG
$138M
| $49.6K | ﹤0.01% |
12,309
-47,097
| -79% | -$174K |
|
|
BZUN
11360
PUT
Baozun
BZUN
$164M
| $49.4K | ﹤0.01% |
+21,100
| New | +$54.6K |
|
|
CMLS
11361
PUT
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $49.4K | ﹤0.01% |
24,200
+9,200
| +61% | +$23.9K |
|
11362
IT Tech Packaging
ITP
$3.06M
| $49.1K | ﹤0.01% |
209,651
| – | – |
|
11363
Solarmax Technology
SMXT
$14.7M
| $49K | ﹤0.01% |
+1,242
| New | +$133K |
|
11364
PUT
PDS Biotechnology
PDSB
$12.5M
| $48.9K | ﹤0.01% |
16,700
-131,100
| -89% | -$419K |
|
|
AMBR
11365
CALL
Amber International Holding Ltd
AMBR
$101M
| $48.9K | ﹤0.01% |
+38,500
| New | +$74.4K |
|
11366
PUT
GrowGeneration
GRWG
$100M
| $48.4K | ﹤0.01% |
22,500
-13,200
| -37% | -$33.5K |
|
|
HOOK
11367
CALL
DELISTED
HOOKIPA Pharma
HOOK
| $48.3K | ﹤0.01% |
8,180
+240
| +3% | +$1.9K |
|
|
TRUE
11368
CALL
DELISTED
TrueCar
TRUE
| $48.2K | ﹤0.01% |
15,400
-2,100
| -12% | -$6.15K |
|
11369
Wearable Devices
WLDS
$5.81M
| $48.1K | ﹤0.01% |
+116
| New | +$35.6K |
|
|
AKTX
11370
Akari Therapeutics
AKTX
$17.7M
| $48.1K | ﹤0.01% |
+431
| New | +$31.8K |
|
|
TVRD
11371
Tvardi Therapeutics
TVRD
$23.7M
| $47.9K | ﹤0.01% |
5,162
+3,445
| +201% | +$82.2K |
|
11372
PUT
Design Therapeutics
DSGN
$976M
| $47.9K | ﹤0.01% |
+14,300
| New | +$55.7K |
|
|
RAPT
11373
CALL
DELISTED
RAPT Therapeutics
RAPT
| $47.9K | ﹤0.01% |
1,963
+238
| +14% | +$11K |
|
11374
Enel Chile
ENIC
$6.18B
| $47.8K | ﹤0.01% |
+17,080
| New | +$50.5K |
|
11375
Lightpath Technologies
LPTH
$828M
| $47.8K | ﹤0.01% |
37,919
+13,189
| +53% | +$18K |
|
Similar funds
Jeff Yass's Q2 2024 Portfolio in Review
As of Q2 2024, Jeff Yass held 13,638 positions worth $537B, down 6.7% from $576B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass withdrew a net $65.7B in Q2 2024, closing 1,726 positions and reducing 5,607 holdings. Its most notable exit was iShares MSCI USA Quality Factor ETF, an estimated $26.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in NextEra Energy 7.299% Corporate Units worth $127M.
- Jeff Yass's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M.
- Jeff Yass added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $521M increase.
- Jeff Yass's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $5.31B.
- Jeff Yass fully exited iShares MSCI USA Quality Factor ETF in Q2 2024, selling an estimated $26.2M.
- Jeff Yass's ten largest holdings make up 26% of its $537B portfolio in Q2 2024.
- Jeff Yass opened 1,591 new positions and closed 1,726 in Q2 2024.
- Jeff Yass's portfolio value fell 6.7% quarter-over-quarter to $537B.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.